PRF Technologies PRFX
NASDAQ PRFX
$0.93 -0.03 (-3.23%)
At close: Sep 22, 2026 · 4:00 PM EDT

PRF Technologies (PRFX) Accumulated Expenses (2019 - 2026)

PRF Technologies' (PRFX) quarterly Accumulated Expenses came in at $235000.0 in Q2 2026, down 41.98% on a YoY basis from $405000.0 in Q2 2025, and down 30.68% quarter-over-quarter from $339000.0 in Q4 2025.

Analysis

PRF Technologies (PRFX) Accumulated Expenses (2019 - 2026) Analysis & Trends

PRF Technologies (PRFX) has reported Accumulated Expenses for 8 consecutive years, with $235000.0 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Accumulated Expenses fell 41.98% year-over-year to $235000.0; the trailing twelve-month figure through Jun 2026 stood at $235000.0 (down 41.98% YoY), and the FY2025 full-year result was $339000.0, up 72.08% from the prior year.
  • Accumulated Expenses declined to $235000.0 in Q2 2026 per PRFX's latest filing, from $339000.0 in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $531000.0 in Q1 2023 and bottomed at $118000.0 in Q4 2023.
  • Historically, Accumulated Expenses has averaged $368714.3 across 5 years, with a median of $385500.0 in 2023.
  • The widest YoY moves for Accumulated Expenses: up 76.41% in 2023, down 76.35% in 2023.
  • Over 5 years, Accumulated Expenses stood at $499000.0 in 2022, then plunged by 76.35% to $118000.0 in 2023, then soared by 66.95% to $197000.0 in 2024, then jumped by 72.08% to $339000.0 in 2025, then sank by 30.68% to $235000.0 in 2026.
  • According to Business Quant data, Accumulated Expenses over the past three periods registered $235000.0, $339000.0, and $405000.0 for Q2 2026, Q4 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 46.72 Bn 43.07 Bn 2.15 Bn
2 Viatris 19.64 Bn 18.75 Bn 1.46 Bn
3 Dr Reddys Laboratories 10.36 Bn 10.22 Bn 396.53 Mn
4 Amneal Pharmaceuticals 6.44 Bn 6.39 Bn 334.51 Mn
5 Bausch Health Companies 2.11 Bn 1.24 Bn 2.10 Bn
6 Ani Pharmaceuticals 1.88 Bn 1.52 Bn 165.89 Mn
7 Alvotech 1.83 Bn 1.69 Bn 2.56 Mn
8 Amphastar Pharmaceuticals 1.04 Bn 751.07 Mn 93.47 Mn
9 Fennec Pharmaceuticals 382.22 Mn 340.97 Mn 17.15 Mn
10 PRF Technologies 622,054.07 -10.31 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 235,000.00
Dec 31, 2025 339,000.00
Jun 30, 2025 405,000.00
Dec 31, 2024 197,000.00
Jun 30, 2024 440,000.00
Mar 31, 2024 520,000.00
Dec 31, 2023 118,000.00
Sep 30, 2023 366,000.00
Jun 30, 2023 501,000.00
Mar 31, 2023 531,000.00
Dec 31, 2022 499,000.00
Sep 30, 2022 414,000.00
Jun 30, 2022 284,000.00
Mar 31, 2022 313,000.00
Dec 31, 2021 423,000.00
Sep 30, 2021 457,000.00
Jun 30, 2021 556,000.00
Mar 31, 2021 582,000.00
Dec 31, 2020 92,000.00
Dec 31, 2019 166,000.00
API Access

PRF Technologies Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=PRFX&period=max&api_key=YOUR_API_KEY